Topic: neuronal targeting

Cancer remains a significant challenge in the medical field (Siegel et al., 2012). Conventional treatments frequently have serious side effects that lower patients' quality of life and cannot totally eradicate the disease (Hendijani, 2015). Additionally, neural progenitor cells might be adversely affected by chemotherapeutic drugs, extinguishing any possibility of nervous tissue regeneration (Dietrich et al., 2006). This emphasizes the importance of precisely targeting cancer cells while preserving healthy brain cells. This work aims at addressing this challenge through the development of poly